EliTech Group
| Primary URL | Location | Industry | elitechgroup[.]com |
Country
France
|
Healthcare
|
|---|
Profile
EliTech Group is engaged in the in-vitro diagnostics sector, focusing on the development and manufacture of diagnostic reagents, instruments, and associated software. Its product portfolio supports clinical laboratories, hospitals, and point-of-care testing environments. The company's solutions are designed to aid in the detection, monitoring, and management of various medical conditions. EliTech Group markets its offerings to healthcare providers and diagnostic service operators worldwide. The firm's headquarters is situated in France.
Described as a global in-vitro diagnostics company, EliTech Group operates across multiple international markets. Its international presence enables it to adapt products to regional regulatory frameworks and clinical workflows. The company's reach includes distribution networks that serve customers in Europe, North America, and other regions. While exact figures for employee count or revenue are not provided in the source material, the characterization as a global player indicates a notable scale of operations. The firm's operational footprint reflects its participation in the worldwide in-vitro diagnostics industry.
EliTech Group's product portfolio includes both conventional diagnostic reagents and software‑enabled instruments. This combination allows the firm to offer integrated solutions for clinical testing workflows. The software components are intended to support data management, result interpretation, and test configuration for end users. In June 2023, the Snatch ransomware gang targeted EliTech Group, using a safe‑mode reboot tactic to evade antivirus controls before stealing and encrypting data. The attack raised concerns about a possible supply chain impact, given that the compromised software is used by downstream laboratories to support their diagnostic operations.